ClinicalTrials.Veeva

Menu

A Study Using 18F-FAPI PET to Evaluate Treatment Response in Pancreatic Adenocarcinoma

Zhejiang University logo

Zhejiang University

Status

Completed

Conditions

Pancreas Adenocarcinoma
Systemic Treatment
18F-FAPI
Pathologic Response

Treatments

Diagnostic Test: 18F-FAPI PET/CT

Study type

Observational

Funder types

Other

Identifiers

NCT06277206
FAPIPDAC02

Details and patient eligibility

About

To explore the potential utility of 18F-FAPI-04 PET/CT for pathologic response evaluation to systemic treatment in PDAC

Enrollment

59 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • suspected to have pancreatic cancer by radiological imaging
  • planned systemic treatment
  • possibility of conversion surgery
  • willingness to participate the study

Exclusion criteria

  • without pathologically confirmed pancreatic cancer
  • poor performance status or organ functions that cannot meet the systemic treatment requirements
  • metastatic disease
  • pregnant patients

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems